• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Comput Biol Chem . Computational analysis of the interactions between Ebselen and derivatives with the active site of the main protease from SARS-Co

tetano

Editor, Senior Moderator
Comput Biol Chem


. 2023 Sep 9;107:107956.
doi: 10.1016/j.compbiolchem.2023.107956. Online ahead of print. Computational analysis of the interactions between Ebselen and derivatives with the active site of the main protease from SARS-CoV-2

Guilherme Schmitt Rieder[SUP] 1 [/SUP], Pablo Andrei Nogara[SUP] 2 [/SUP], Folorunsho Bright Omage[SUP] 3 [/SUP], Tâmie Duarte[SUP] 1 [/SUP], Cristiane Lenz Dalla Corte[SUP] 1 [/SUP], João Batista Teixeira da Rocha[SUP] 4 [/SUP]



Affiliations
Abstract

The main protease (M[SUP]pro[/SUP]) of the novel coronavirus SARS-CoV-2 is a key target for developing antiviral drugs. Ebselen (EbSe) is a selenium-containing compound that has been shown to inhibit Mpro in vitro by forming a covalent bond with the cysteine (Cys) residue in the active site of the enzyme. However, EbSe can also bind to other proteins, like albumin, and low molecular weight compounds that have free thiol groups, such as Cys and glutathione (GSH), which may affect its availability and activity. In this study, we analyzed the M[SUP]pro[/SUP] interaction with EbSe, its analogues, and its metabolites with Cys, GSH, and albumin by molecular docking. We also simulated the electronic structure of the generated molecules by density functional theory (DFT) and explored the stability of EbSe and one of its best derivatives, EbSe-2,5-MeClPh, in the catalytic pocket of Mpro through covalent docking and molecular dynamics. Our results show that EbSe and its analogues bound to GSH/albumin have larger distance between the selenium atom of the ligands and the sulfur atom of Cys145 of M[SUP]pro[/SUP] than the other compounds. This suggests that EbSe and its GSH/albumin-analogues may have less affinity for the active site of Mpro. EbSe-2,5-MeClPh was found one of the best molecules, and in molecular dynamics simulations, it showed to undergo more conformational changes in the active site of Mpro, in relation to EbSe, which remained stable in the catalytic pocket. Moreover, this study also reveals that all compounds have the potential to interact closely with the active site of Mpro, providing us with a concept of which derivatives may be promising for in vitro analysis in the future. We propose that these compounds are potential covalent inhibitors of M[SUP]pro[/SUP] and that organoselenium compounds are molecules that should be studied for their antiviral properties.

Keywords: Ebselen; Glutathione; M(pro); Molecular Docking; SARS-CoV-2.

 
Back
Top Bottom